Upon activation, T cells require energy for growth, proliferation, and function. Effector T (Teff) cells, such as Th1 and Th17 cells, utilize high levels of glycolytic metabolism to fuel proliferation and function. In contrast, Treg cells require oxidative metabolism to fuel suppressive function. It remains unknown how Teff/Treg-cell metabolism is altered when nutrients are limited and leptin levels are low. We therefore examined the role of malnutrition and associated hypoleptinemia on Teff versus Treg cells. We found that both malnutrition-associated hypoleptinemia and T cell-specific leptin receptor knockout suppressed Teff-cell number, function, and glucose metabolism, but did not alter Treg-cell metabolism or suppressive function. Using the autoimmune mouse model EAE, we confirmed that fasting-induced hypoleptinemia altered Teff-cell, but not Treg-cell, glucose metabolism, and function in vivo, leading to decreased disease severity. To explore potential mechanisms, we examined HIF-1α, a key regulator of Th17 differentiation and Teffcell glucose metabolism, and found HIF-1α expression was decreased in T cell-specific leptin receptor knockout Th17 cells, and in Teff cells from fasted EAE mice, but was unchanged in Treg cells. Altogether, these data demonstrate a selective, cell-intrinsic requirement for leptin to upregulate glucose metabolism and maintain function in Teff, but not Treg cells.
Introduction

Upon activation, CD4
+ T cells need to rapidly grow, divide, and produce cytokines to mount an immune response. CD4 + T cells also differentiate into distinct subtypes that have unique roles in immunity. Effector CD4 + T (Teff) cells, such as Th1 and Th17 cells, drive the immune response through secretion of inflammatory cytokines, while Treg cells suppress effector responses to inhibit autoimmunity [1] . The balance between Teff and Treg cells is critical to provide normal immunity without excessive inflammation and autoimmunity. Th17, in particular, are highly proinflammatory and contribute to many autoimmune diseases including multiple sclerosis in humans and the mouse model of EAE [2, 3] . Additionally, nonclassic Th17-derived Th1 cells play a key role in chronic inflammatory disorders and autoimmunity [4] . A proper balance between Th1, Th17, and Treg subsets is crucial to prevent these and other autoimmune diseases [5] .
It is now appreciated that T-cell metabolism is directly linked to T-cell function [6] [7] [8] [9] [10] [11] [12] . Teff cells, including Th1 and Th17 cells, require large amounts of glucose for aerobic glycolysis, which fuels T-cell function and produces biosynthetic precursors for cell growth and division [10, 11, 13] . Activated Teff cells primarily take up glucose via the glucose transporter Glut1. Glut1 expression has been shown to be critical for Teff-cell glucose metabolism, proliferation, and inflammatory cytokine production [7] . Interestingly, Treg cells do not require Glut1 and instead utilize oxidative metabolism for energy and suppressive function [7, 10, 12, 14, 15] . While these findings clarify the metabolic needs of distinct CD4 + T-helper subsets, it remains unclear how CD4 + T-cell differentiation and subset metabolism are affected in malnutrition when nutrients are limited. The adipocyte-secreted hormone leptin provides a link between nutritional status and immunity [16] [17] [18] . Leptin is secreted in proportion to adipocyte mass and is therefore decreased in malnutrition [16] . While leptin is well-described to regulate food intake, energy expenditure, and body weight, leptin has also been shown to play a critical role in regulating immunity and functions as a proinflammatory cytokine [18, 19] . Low levels of leptin are associated with high rates of death from infectious diseases [16] . In a recent study of childhood malnutrition, low circulating leptin levels were found to be the single most important biomarker to predict mortality in malnourished Ugandan infants [20] . We and others have demonstrated that leptin deficiency and fastinginduced hypoleptinemia have dramatic effects on T cells, including reduced T-cell numbers, decreased Teff cells, increased Treg-cell responses, and protection against certain forms of autoimmune disease [17, 18, [21] [22] [23] [24] [25] . With a few key exceptions [22, 26] , most of the previous studies were limited because they described T-cell subset alterations in whole body leptin and leptin receptor mutant animals. Since leptin is a pleiotropic hormone that can alter many different cells in addition to T cells, it is possible that some of the previously observed effects of leptin on T-cell differentiation and function were mediated through indirect, cell-extrinsic mechanisms.
In our previous work, we found that leptin is required to upregulate CD4
+ T-cell glucose metabolism upon activation, but did not have any effect on naïve cells [17] . However, it remains unclear if leptin can differentially alter Teff versus Treg-cell metabolism and thereby selectively alter cellular function upon activation. Because leptin is a pleiotropic hormone, we generated a T cell-specific leptin receptor knockout mouse to examine the direct effect of leptin on Teff/Treg-cell differentiation and metabolism. We found that both fasting-induced hypoleptinemia and T cell-specific leptin receptor knockout led to decreased Teff-cell number, glucose metabolism, and function. In contrast, Treg cells were preserved in the context of fasting and were unaffected by the presence of additional leptin or by T cell-specific leptin receptor knockout.
To study the role of leptin and nutrition on Teff versus Tregcell metabolism and function in vivo, we used a mouse model of multiple sclerosis, EAE. We found fasting-induced hypoleptinemia decreased IFN-γ and IL-17 production as well as expression of a key glycolytic enzyme in Th17 cells, but not Treg cells, in EAE mice. These findings correlated with protection against autoimmune disease, and were reversed with leptin injections. Lastly, to explore potential mechanisms of hypoleptinemia-induced Teff dysfunction, we examined HIF-1α, a key regulator of Th17-cell differentiation and Teff-cell glucose metabolism [9] . We found leptin signaling increased expression of the glycolysis-promoting transcription factor HIF-1α in Th17 cells, but not in Treg cells. Moreover, HIF-1α expression was decreased in Th1 and Th17 cells, but not Treg cells, from fasted EAE mice. These findings suggest that leptin signaling to promote glucose metabolism may be mediated, in part, by HIF-1α. Thus, leptin provides a key link between nutritional status and immunity by playing a selective cell-intrinsic role to promote glucose metabolism in Teff cells and drive inflammatory T-cell responses.
Results
Fasting-induced hypoleptinemia suppresses Th17-cell viability and metabolism
Previous studies have shown that T cells express the full-length leptin receptor (ObR) and can respond to leptin [27] . While leptin has been implicated to promote effector Th1 and Th17 cells and suppress Foxp3-expressing Treg proliferation [21, 24, 28] , the mechanism by which leptin exerts an effect on T cells has been uncertain. Here, we examined the role of leptin in Teffcell and Treg-cell metabolism and differentiation. C57BL/6J mice were either fed ad libitum (control) or fasted for two days with or without twice daily leptin injections. the T-cell compartment and this increased percentage of Treg cells in fasted animals was unaffected by leptin administration (Fig. 1C) .
We next examined Th17 and Treg-cell differentiation following fasting. CD4 + T cells were isolated from fed control mice, or mice that had been fasted for 48 h with or without leptin administration, and differentiated into Th17 or Treg cells in vitro, after which cell viability was measured. Th17-cell viability was reduced following fasting, but was restored in fasted mice receiving leptin injections (Fig. 1D ). In contrast, in vitro differentiated Treg cells from fasted animals showed increased viability compared to Treg cells from fed control mice, and this increased viability of Treg cells in fasted animals was unchanged by the addition of leptin. Together, these data suggest that while Th17-cell numbers are altered by leptin levels, Treg cells remain unaffected. Teff and Treg cells are known to have different metabolic profiles, which may alter Th17 and Treg-cell survival following fasting [10, 11] . Teff cells rely on high levels of glucose uptake and glycolysis to drive Teff-cell function, while Treg cells have been shown to instead rely on mitochondrial oxidation. We have previously shown that leptin promotes glucose metabolism in activated CD4 + T cells but does not affect naïve T-cell metabolism [17] . Here, we examined the effects of leptin on effector versus regulatory T-cell metabolism. Glucose metabolism was examined in Th17 and Treg cells from fasted mice versus ad libitum fed controls. Th17 cells from fed mice had a higher rate of glucose uptake and glycolysis compared to Treg cells, as described [12] . However, Th17 cells from fasted mice had significantly decreased levels of both glucose uptake and glycolytic rate compared to Th17 cells from fed controls ( Fig. 2A and B) . This defect in glucose metabolism seen in Th17 cells from fasted animals was reversed when fasted mice received leptin injections. In contrast, leptin administration had a modest effect to increase glucose uptake in Treg cells from fasted animals, but overall had little effect on Treg-cell glycolytic rate and glucose metabolism.
Downstream of glucose uptake and glycolysis (conversion of glucose to pyruvate), glucose-derived pyruvate can either be converted to lactate and secreted or oxidized in the TCA cycle in the mitochondria. We therefore performed extracellular flux analysis in both Th17 and Treg cells from fed versus fasted animals and in fasting animals receiving leptin injections. We found a decrease in both extracellular acidification rate (ECAR; a surrogate marker of lactate production) and oxygen consumption rate (OCR; a surrogate marker of mitochondrial respiration) in Th17 cells from fasted animals compared to Th17 cells from fed controls (Fig. 2C  and D) . Treatment of fasted animals with twice daily leptin injections rescued the decreased ECAR and OCR levels observed in Th17 cells following fasting. Treg cells, however, showed equivalent levels of ECAR and OCR in cells from fed mice, fasted mice, and fasted mice treated with leptin ( Fig. 2C and D) . As effector T cells are also known to increase glutamine oxidation upon activation, we examined OCR levels in Th17 cells from fed mice, fasted mice, and fasted mice treated with leptin following culture in the presence or absence of glutamine. We found that glutamine depletion led to reduced OCR in Th17 cells from fed control mice and in fasted mice treated with leptin, whereas reduced glutamine did not further alter the already lower OCR levels in Th17 cells from fasted animals (Fig. 2E) . Lastly, we measured OCR levels in Th17 cells before and after treatment with the ATP synthase inhibitor oligomycin, in order to calculate the ATP production from mitochondrial oxidation of fuels, in fed versus fasted animals and in fasted animals treated with leptin. As suspected, mitochondrial ATP production was reduced in Th17 cells from fasted animals, and this reduction was reversed when fasted animals were treated with leptin ( Fig. 2F) . Altogether, these data demonstrate that Th17 cells from fasted animals have decreased viability, glycolytic metabolism, and mitochondrial respiration, which can be reversed with leptin injections, whereas Treg-cell viability, glucose metabolism, and mitochondrial oxidation are not significantly altered by fasting or leptin. 
Fasting-induced hypoleptinemia suppresses Th17-cell, but not Treg-cell, proliferation, and function
Since fasting-induced hypoleptinemia led to selective alterations in Th17-cell, but not Treg-cell, viability and metabolism, we next sought to examine the effects of fasting and altered leptin levels on CD4
+ T-cell proliferation and differentiation. Previous studies have shown that whole body leptin-deficient and leptin receptordeficient mouse mutants have decreased T-cell proliferation [17] . We found that Th17 cells from fasted mice also had decreased cell proliferation, and this decrease was partially rescued by in vivo leptin administration (Fig. 3A) . In contrast, Treg cells from fasted mice had similar or slightly elevated proliferation compared to Treg cells from fed animals, and proliferation did not significantly change in Treg cells from fasted mice receiving leptin injections. We next examined Th17-cell and Treg-cell function in fed versus fasted mice and in fasted mice receiving leptin injections.
CD4
+ T cells were isolated from these experimental groups and differentiated into Th17 and Treg cells in vitro. Th17-cell function, as measured by IL-17 production, was reduced following fasting and restored if the fasted animals received leptin injections in vivo, suggesting that hypoleptinemia suppresses Th17 cells (Fig. 3B) . We also compared in vitro differentiated Th17 cells that were grown in culture in the presence of IL-2 versus IL-23 following in vitro differentiation, and found similar behavior in Th17-cell number, function, and metabolism from fed versus fasted animals and from fasted animals receiving leptin injections cultured with IL-2 or IL-23 (Supporting Information Fig. 1A and B). Treg-cell differentiation and suppressive function were similar in both control fed and fasted conditions, with or without leptin administration ( Fig. 3C and D) . These data suggest that leptin promotes Th17-cell proliferation and differentiation or function, but has a smaller and less significant effect on Treg cells. Because starvation represents a severe phenotype of malnutrition, which is associated with multiple systemic changes in hormone levels, we confirmed our findings on T-cell metabolism and function in a model of chronic calorie restriction. Here, mice were either fed ad libitum or calorie-restricted to 50% of their usual daily intake for 2 weeks. The calorie-restricted mice lost approximately the same amount of weight as 48 h fasting, and had decreased circulating leptin levels (Supporting Information Fig. 2A ) [17] . IL-17 production in induced Th17 cells was decreased upon calorie-restriction whereas Treg-cell differentiation was unaffected (Supporting Information Fig. 2B ). These results were similar to those obtained following 48-h fasting. Likewise, glucose uptake and the rate of glycolysis were suppressed in Th17 cells from calorie-restricted animals, but unchanged in Treg cells (Supporting Information Fig. 2C and D) . Altogether, these data show that hypoleptinemia due to malnutrition through both short-and long-term calorie restriction alters Th17-cell metabolism and function, whereas Treg cells, which are less glycolytic than Th17 cells, are less susceptible to changes in nutritional status, as seen in both fasting and calorie restriction mouse models.
Leptin signaling specifically regulates Teff-cell differentiation and function
Given the importance of leptin in rescuing Th17-cell metabolism and function in fasting, we next sought to examine the intrinsic role of leptin signaling in Th17 and Treg-cell differentiation. A recent report demonstrated that Th17 cells from a T cell-specific leptin receptor knockout mouse showed reduced capacity for differentiation and decreased STAT3 activation [22] . Other previous reports have examined the role of leptin on T-cell differentiation and function in the context of whole body leptin or leptin receptor deficiency [24, [29] [30] [31] . Since leptin is a pleiotropic hormone that may influence T-cell development and function indirectly, we examined CD4
+ T-helper cell metabolism and function using a T cell-specific leptin receptor knockout mouse (CD4CreLepR F/F ).
CD4CreLepR
F/F animals showed no developmental abnormalities, with similar CD4 + and CD8 + levels in the thymus and spleen (Supporting Information Fig. 3A ). CD4 + T cells isolated from CD4CreLepR F/F mice also activated normally and expressed similar levels of the surface markers CD44, CD25, and CD69, compared to T cells from control mice (Supporting Information Fig. 3B ).
To examine the effect of T cell-intrinsic leptin receptor deficiency on Teff-cell function, T cells were isolated from CD4CreLepR F/F mice and in vitro differentiated into Th17 cells.
In agreement with a recent study, differentiated Th17 cells from CD4CreLepR F/F mice produced a lower percentage of IL-17-producing cells compared to Th17 cells from control animals (Fig. 4A ) [22] . The absolute number of IL-17-producing cells was also decreased in the CD4CreLepR F/F knockout animals (Fig. 4B ). Th17 cells from CD4CreLepR F/F mice also expressed decreased levels of the Th17-associated transcription factor RORγt (Fig. 4C) . These results confirm that T cell-intrinsic leptin receptor signaling directly regulates Th17-cell differentiation and function. Similar to Th17 cells, we also found that differentiated Th1 cells from CD4CreLepR F/F mice produced a lower percentage of IFN-γ-producing cells compared to Th1 cells from control animals (Supporting Information Fig. 3C ). Next, we examined Treg-cell differentiation and found that CD4CreLepR F/F T cells skewed in vitro with TGFβ had a higher percentage of Foxp3-expressing cells as compared to in vitro differentiated Treg cells from control mice (Fig. 4D) . However, there was no difference in the absolute number of Foxp3-expressing Treg cells from CD4CreLepR F/F versus control mice (Fig. 4E ).
Treg cells from CD4CreLepR F/F mice also had similar suppressive capacity as Treg cells from control animals, as measured by an in vitro suppression assay (Fig. 4F) . These findings suggest that nonTreg CD4 + T cells are selected against in leptin deficiency, and that leptin deficiency does not directly promote Treg-cell number. Together, these data show that T cell-intrinsic leptin receptor signaling specifically promotes Teff-cell differentiation and function whereas absolute Treg-cell number and function remained largely unaffected.
Leptin signaling regulates Teff-cell glucose metabolism in a cell-intrinsic manner
To determine if fasting-induced changes in T-cell glucose metabolism were due to T cell-intrinsic effects of leptin, CD4 + T cells from CD4CreLepR F/F or control mice were in vitro differentiated to Th17 or Treg cells and glucose metabolism was examined. RNA expression of both Glut1 and hexokinase 2 (HK2; the first enzyme in the glycolytic pathway) was decreased in Th17 from CD4CreLepR F/F mice compared to Th17 cells from control animals ( Fig. 5A and B (Fig. 5C ), and glucose uptake was decreased in Th1 and Th17 cells from CD4CreLepR F/F mice ( Fig. 5D and Supporting Information Fig. 3D ). While glucose uptake was lower in Treg cells compared to Th17 cells from control animals, it was unchanged in Treg cells in the absence of T cell-specific leptin signal. We have previously shown that glycolysis is also decreased in Th17 cells from CD4CreLepR F/F mice, but unchanged in Treg cells from CD4CreLepR F/F mice [17] , and did not repeat that here.
Once glucose is taken up by the T cell and converted into pyruvate, it can be either converted into lactate or oxidized in the mitochondria. We therefore examined lactate production in Th17 and Treg cells from CD4CreLepR F/F and control mice, and found that Th17 cells lacking leptin receptor expression had slightly, albeit significantly, decreased production of lactate compared to Th17 cells from control mice (Fig. 5E ). Treg cells produced lower lactate than Th17 cells, and Treg-cell lactate production was unaffected by leptin receptor deficiency. These data suggest that leptin signaling directly regulates T-cell metabolism through increased Glut1 expression, glucose uptake, and glucose metabolism in Th1 and Th17 cells, but not Treg cells.
Fasting-induced hypoleptinemia inhibits Th1-cell and Th17-cell function to alleviate EAE
It has been previously observed that fasting or calorie-restriction can inhibit autoimmune disease in EAE [32] . One possible mechanism for this is through lower levels of leptin. Indeed, leptin has been shown to increase EAE symptoms in both wild-type and leptin mutant ob/ob mice [33, 34] , whereas leptin-neutralization can inhibit EAE [35] . The immune response observed in EAE is at least partly Th17-cell-dependent, as RORγt and IL-17 knockout mice are resistant to EAE [36, 37] . Here, we examined the effect of fasting-induced hypoleptinemia on Th1, Th17, and Treg-cell number, function, and metabolism in vivo, using an EAE mouse model. Mice were fed or fasted with or without leptin injections for 48 h at the onset of EAE initiation and then remained fed ad libitum for the remainder of the experiment. Control mice received PBS injections of similar volume. Fasted mice had lower EAE clinical scores (less severe disease) and decreased CD4 + numbers compared to control fed animals ( Fig. 6A and B) . Additionally, mice that were fasted but received leptin injections during the fast had more severe disease than fasted mice that received PBS injections, demonstrating that leptin alone is able to reverse the protection against autoimmunity seen in fasting.
We also examined T-cell function and metabolism in vivo in the EAE mouse model. T cells isolated from the spleen and draining lymph nodes of fasted mice on day 9 (during EAE onset) showed decreased levels of IL-17 production compared to T cells isolated from fed control mice, whereas T cells isolated from the draining lymph nodes (but not from spleen) of fasted mice showed decreased levels of IFN-γ production ( Fig. 6C and D) . Treatment of fasted mice with leptin was sufficient to rescue IL-17 and IFN-γ production, similar to what was seen in our in vitro studies. In contrast, there was an increase in the percentage of Foxp3-expressing Treg cells in splenic T cells from fasted mice, compared to fed mice in our EAE studies (Fig. 6E) , and this was reversed when fasted mice received leptin injections. In the inguinal lymph nodes, the percentage of T cells expressing Foxp3 remained elevated in fasted mice treated with leptin. These data suggest that hypoleptinemia can inhibit Th1 and Th17-cell function in vivo while fasting itself leads to an increase in percentage of Treg cells.
To evaluate T-cell glycolytic metabolism in EAE, T cells from mice undergoing EAE induction were examined for the expression of HK2, a critical enzyme in glucose metabolism that correlates to glucose uptake and glycolytic rates [10] mice, and this decrease in HK2 expression in Th17 cells in fasting was reversed by leptin administration. In contrast, there was no statistical difference between HK2 levels in Treg cells from EAE mice that were fed, fasted, or fasted while receiving leptin injections. Altogether, these data suggest that fasting and associated hypoleptinemia inhibit Teff-cell glucose metabolism, differentiation, and effector function, without affecting Treg-cell metabolism and function in vivo.
Leptin signal regulates HIF-1α expression in Th17 cells, but not Treg cells
Leptin is known to promote PI3K/Akt/mTOR signaling in both T cells and other cell types [38] . We examined activated CD4 Information Fig. 4A ). However, it is not known if the effects of leptin on signaling pathways are due to direct or indirect effects of leptin on T cells. We therefore examined the effect of T cell-intrinsic leptin signaling on PI3K/Akt/mTOR and AMP kinase (AMPK) activation in Th17 and Treg cells. Surprisingly, there was no change in phospho-Akt, phospho-mTOR, phospho-S6K, or phospho-AMPK in either Th17 or Treg cells from CD4CreLepR F/F mice compared to control littermates (Supporting Information Fig. 4B ). Another signaling pathway important for Th17-cell metabolism and function is through the protein HIF-1α, which has been described as a critical regulator of RORγt expression and Th17-cell differentiation [39] [40] [41] [42] . HIF-1α is also known to promote T-cell glycolytic metabolism [9] . We therefore examined HIF-1α expression in the T cell-specific leptin receptor knockout. Compared to Th17 cells from control mice, and in agreement with previous studies [22] , HIF-1α mRNA and protein expression were decreased in Th17 cells from CD4CreLepR F/F mice ( Fig. 7A-C) . The expression of HIF-1α was lower in Treg cells compared to Th17 cells from control animals, but was unaffected by the absence of leptin signal in Treg cells. We also examined HIF-1α levels in Th1, Th17, and Treg cells from fed mice, fasted mice, and fasted mice receiving leptin injections, in the EAE model. HIF-1α levels were significantly decreased in both Th1 and Th17 cells isolated from spleens from fasted EAE mice compared to fed control EAE mice, and this decrease in HIF-1α expression in Teff cells from fasted animals in EAE was reversed by leptin administration (Fig. 7D) . In Treg cells, the expression of HIF-1α was about threefold lower than in Th1 and Th17 cells. In addition, there was a small but significant decrease in HIF-1α expression in Treg cells from fasted animals, but no change in HIF-1α expression in Treg cells when fasted animals were treated with leptin (Fig. 7D) . In Th1 and Th17 cells isolated from draining lymph nodes, there were small changes in HIF-1α expression that did not reach statistical significance, and may therefore represent a timing issue (Supporting Information Fig. 4C ). Altogether, these findings suggest that a key role of leptin in CD4 + T cells may be to regulate HIF-1α expression and thereby influence T-cell glucose metabolism and Teff-cell differentiation and function.
Discussion
Whole body nutritional status can alter immune responses. Malnutrition is associated with immunosuppression and increased mortality from infection. In addition, malnutrition through fasting or calorie restriction has been found to protect against several forms of autoimmunity, including EAE [32, 43] . The adipocytesecreted hormone leptin plays a key role in communicating nutrient status to the immune system and may therefore be a critical regulator of immunity during malnutrition. We and others have demonstrated previously that leptin is required for normal T-cell function [17, 18, 24] . We show here that leptin augments Th1-cell and Th17-cell, but not Treg-cell, number and function directly through its ability to upregulate T-cell glycolytic metabolism and thereby fuel Teff-cell activation in the fed state. In these studies, we examined the role of fasting inducedhypoleptinemia on Teff versus Treg-cell function and metabolism in vivo in the context of EAE. Leptin deficiency induced by fasting led to a decrease in EAE disease severity, along with decreased IFN-γ and IL-17 production as well as decreased Teff-cell glycolytic enzyme expression. These Teff-cell defects were rescued when leptin was administered in vivo during the fast. In contrast, Treg-cell numbers increased during the fast and remained elevated despite leptin injections, and Treg-cell metabolic enzyme expression was unchanged. These data are in agreement with our in vitro findings in both fasting-induced hypoleptinemia and T cell-specific leptin receptor knockout mice.
While a role for leptin in T cells have been observed previously, it is important to note that many of those studies have been in the context of whole body leptin or leptin receptor deficiency, and given the pleiotropic effects of leptin, the cell-intrinsic role of leptin on differentiated CD4
+ T cells has remained unclear.
However, one recent study did show that T cell-specific leptin deficiency altered Th17 differentiation and inhibited STAT3 signaling [22] , while another interesting study reported leptin can directly cooperate with IL-6 to promote Th17-cell differentiation in the context of a T cell-specific MAP4K4 deficiency, thereby altering insulin sensitivity [26] . Our study adds to those findings to show that leptin acts directly on effector Teff cells to promote glucose metabolism and thereby fuel effector function. But whereas T cell-specific leptin deficiency inhibits Teff-cell differentiation, metabolism, and function, it has little effect on Treg cells. Previous studies that examined the role of leptin signaling on Treg cells using whole-body leptin and leptin receptor mutant animals have demonstrated increased Treg-cell proliferation and function [28] . Using our T cell-specific leptin receptor knockout animal, we show that Treg-cell metabolism and function are not significantly affected by intrinsic leptin deficiency. Although the percentage of Treg cells increases in this context, it is likely due to inhibition of the non-Treg-cell compartment, as we observed that the absolute number of Treg cells remained constant in both fasting-induced hypoleptinemia and the T cell-specific leptin receptor knockout model. We believe that the mechanism by which leptin intrinsically alters Teff versus Treg cells differentially is through its ability to alter T-cell glucose metabolism. Our previous study suggests that leptin-mediated upregulation of glucose metabolism is critical during T-cell activation, in part through upregulation of the glucose transporter Glut1. Moreover, transgenic expression of Glut1 rescued glucose metabolism and function in activated T cells from fasted mice [17] . Similarly, Teff cells express high levels of Glut1 and high rates of glucose uptake and glycolysis [7, 10, 12] . We show here that leptin plays a role in Teff cells to increase glucose metabolism and effector function. This role of leptin is cellintrinsic, as specific deletion of leptin receptor in CD4 + T cells led to decreased Teff-cell metabolism and function. We were also [10] [11] [12] . Instead, Treg cells rely on an oxidative metabolism utilizing lipids and glucose through mitochondrial oxidation and have low levels of Glut1 and glucose uptake. In this way, Treg cells are metabolically more similar to naïve CD4 + T cells than inflammatory effector T cells. We observed
here that Treg cells from fasted mice or from T cell-specific leptin receptor-deficient mice are metabolically and functionally similar to those of control mice. This is similar to what we have observed previously in naïve T cells [17] , and suggests that leptin is not required for either resting T-cell or Treg-cell metabolism or function. Leptin receptor expression is induced upon T-cell activation [44] and signals through a variety of intracellular pathways including PI3K/Akt/mTOR, Jak/STAT, and MAPK signaling [45] . The PI3K/Akt/mTOR pathway is also involved in T-cell metabolism [9, 46] . Teff cells, including Th17 cells, express mTOR complex 1 (mTORC1) while Treg cells have low levels of mTOR signaling [14] . In fact, PTEN-knockout Treg cells that are forced to utilize the PI3K/Akt/mTOR pathway are not functional in vitro or in vivo [47] . We examined members of this pathway, including Akt, mTOR, S6, 4EBP, and AMPK, and surprisingly did not find significant changes with T cell-specific leptin receptor deficiency in the conditions we examined. Therefore, the changes to the Akt/mTOR pathway seen in T cells from whole body leptin or leptin receptor knockout studies may have been due to indirect and cell-extrinsic influences.
Another signaling pathway critical for Th17-cell metabolism and function is the HIF-1α pathway [11, 48] . In T cells, HIF-1α has been found to promote Th17-cell differentiation. Although not important in early T-cell activation, HIF-1α is selectively expressed in the Th17-cell subset and critical to upregulate glucose metabolism [11] . HIF-1α also modulates the balance between Th17 and Treg cells, as a T cell-specific HIF-1α knockout promoted Treg-cell generation and inhibited IL-17 production, protecting against EAE in vivo [11] , and recent studies support the important role for HIF-1α regulation in Th17-cell differentiation in inflammatory disorders [49] . HIF-1α can act directly to increase RORγt activity, bind to and degrade Foxp3, and also upregulate a variety of glucose metabolism genes [11, 48] . We found that cell-intrinsic leptin receptor deficiency led to an inhibition of HIF-1α expression at both the mRNA and protein level in Th17 cells, but not Treg cells. In addition, HIF-1α levels were decreased in Th1 and Th17 cells isolated from mice undergoing EAE induction. The role of HIF-1α in Th1 cells in EAE is less clear than its role in Th17 cells, but may be explained by the observation that nonclassic Th17-derived Th1 cells play a key role in chronic inflammatory disorders and autoimmunity [4] . Altogether, HIF-1α signaling may contribute to the metabolic and functional defects seen in leptindeficient Teff cells, and represents a mechanism by which leptin regulates Teff-cell glucose metabolism, differentiation, and function.
Materials and methods
Mice
C57BL/6J mice (8-10 weeks) were purchased from The Jackson Laboratory (Bar Harbor, ME) and used for experiments unless otherwise specified. CD4CreLepR knockout mice were generated by crossing CD4-Cre transgenic mice with LepR floxed mice (Jackson Laboratory). For fasting studies, mice were deprived of food for 48 h but allowed full access to water. Where specified, 1 μg/gram body weight recombinant leptin (R&D Systems, Minneapolis, MN) was injected intraperitoneally twice daily during the 48-h fast. Control mice received PBS injections. All animal studies were approved by the Institutional Animal Care and Use Committee of Duke University, an institution accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), International.
T-cell differentiation
Splenic CD4
+ T cells were purified by negative selection (Miltenyi Biotec, Auburn, CA) and differentiated into Th17 and Treg cells as previously described [12] . Briefly, T cells were cultured for 3 days in the presence of irradiated splenic feeder cells (3000 rad) with 2.5 μg/mL soluble anti-CD3. The following cytokines were added to each subset: Th17, 20 ng/mL IL-6 (R&D Systems), 2.5 ng/mL TGFβ (R&D Systems), 10 μg/mL anti-IFN-γ; Treg, 3 ng/mL TGFβ. Three days after stimulation, cells were split 1:2 and replated with IL-2 alone for an additional 2 days.
Flow cytometry
Proliferation was determined by staining T cells with CFSE (Invitrogen, Chicago, IL) before culture and analyzed by dilution of fluorescent dye flow cytometrically. Viability was determined by propidium iodide exclusion (PI; Invitrogen). Intracellular cytokines and transcription factors were measured as described previously [10] . Intracellular staining for hexokinase 2 (HK2; Abcam, ab131196, Cambridge, MA), Glut1 (Abcam, ab652), and HIF1-α (R&D Systems, MAB1536) required an additional 30 min incubation for secondary PE antibody (eBioscience, San Diego, CA). All flow cytometry was performed on a MACSQuant Analyzer (Miltenyi) and analyzed with FlowJo software (Tree Star, Ashland, OR).
Metabolic assays
The glycolytic flux and glucose uptake assays using 3 H-glucose or 3 H-deoxyglucose were performed as described previously [17] .
OCR and ECAR were measured with an extracellular flux analyzer (Seahorse Bioscience, North Billerica, MA).
Quantitative real-time PCR and immunoblotting mRNA was isolated from Th17 or Treg using the Qiagen kit and cDNA was synthesized using the iScript cDNA synthesis kit (BioRad, Hercules, CA). All samples were normalized to actin mRNA levels. For immunoblotting, cells were lysed as previously described [17] . The following antibodies were used: Glut1 (Abcam, ab652), HIF-1α (Cayman Chemical, Ann Arbor, MI), phospho-Akt, total Akt, phospho-mTOR, total mTOR, phospho-S6, total S6, phospho-AMPK, and total AMPK (Cell Signaling, Beverly, MA).
Treg suppression assay
Treg cells were differentiated as described above and cultured at a ratio of 1:1 with CFSE-labeled CD8 + T cells with irradiated splenic feeder cells (1:5 ratio) and 1 μg/mL soluble anti-CD3. Treg-cell suppression of CD8 + T-cell proliferation was determined 72 h poststimulation by CFSE dilution using flow cytometry.
Experimental autoimmune encephalomyelitis
EAE was induced as previously described [10, 50] . Briefly, wildtype C57BL/6J mice were injected s.c. with 100 ng MOG peptide (New England Peptide, Gardner, MA) mixed with Complete Freund's Adjuvant (Sigma, St. Louis, MO) with 2 mg/mL heat-killed Mycobacterium tuberculosis followed by pertussis toxin (200 ng per mouse) administrated by i.p. injection on day 0 and 2. Where indicated, on day 0, mice were fasted for 48 h and received twice daily leptin or PBS i.p injections. After 48 h fasting, mice were allowed to feed ad libitum for the remainder of the experiment. Clinical signs of EAE were assessed according to the following disease scoring parameters: 0, no signs of disease; 1, loss of tone in the tail; 2, impaired righting reflex; 3, hindlimb paralysis; 4, tetraplegia/death. For T-cell functional data, cells were isolated from the draining inguinal lymph nodes on day 9 postimmunization.
Statistical analysis
The data are presented as mean ± SD and were analyzed using a two-tailed Student t test. Statistically significant results are indicated (*p < 0.05). For the EAE experiment, data were analyzed by two-way ANOVA with Prism software (GraphPad).
